A detailed history of Latitude Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Latitude Advisors, LLC holds 2,571 shares of ABBV stock, worth $424,189. This represents 0.33% of its overall portfolio holdings.

Number of Shares
2,571
Previous 2,632 2.32%
Holding current value
$424,189
Previous $451,000 12.42%
% of portfolio
0.33%
Previous 0.32%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$163.84 - $199.33 $9,994 - $12,159
-61 Reduced 2.32%
2,571 $507,000
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $10,525 - $12,291
68 Added 2.65%
2,632 $451,000
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $3,995 - $4,552
25 Added 0.98%
2,564 $466,000
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $79,257 - $89,262
-576 Reduced 18.49%
2,539 $393,000
Q3 2023

Nov 03, 2023

SELL
$133.59 - $154.65 $56,909 - $65,880
-426 Reduced 12.03%
3,115 $464,000
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $31,139 - $38,751
235 Added 7.11%
3,541 $477,000
Q1 2023

Apr 27, 2023

SELL
$144.61 - $166.54 $6,362 - $7,327
-44 Reduced 1.31%
3,306 $526,000
Q4 2022

Jan 27, 2023

BUY
$138.31 - $165.87 $68,048 - $81,608
492 Added 17.21%
3,350 $0
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $44,423 - $50,950
331 Added 13.1%
2,858 $384,000
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $702,137 - $892,645
-5,102 Reduced 66.88%
2,527 $387,000
Q1 2022

Apr 29, 2022

BUY
$131.98 - $163.75 $435,138 - $539,883
3,297 Added 76.11%
7,629 $1.24 Million
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $152,872 - $193,428
1,423 Added 48.92%
4,332 $587,000
Q3 2021

Oct 14, 2021

BUY
$106.4 - $120.78 $309,517 - $351,349
2,909 New
2,909 $314,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Latitude Advisors, LLC Portfolio

Follow Latitude Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Latitude Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Latitude Advisors, LLC with notifications on news.